“…Our ongoing research program focuses on the design of rapid, convergent and efficient IMCR/post-transformation strategies toward novel molecules containing privileged heterocycles: azepino[4,5- b ]indol-4-ones (Rentería-Gómez et al, 2016b), 2-tetrazolylmethyl-isoindolin-1-ones (Rentería-Gómez et al, 2016a), tetrazolo[1,5- a ]quinolines (Unnamatla et al, 2016), 3-tetrazolylmethyl-azepino[4,5- b ]indol-4-ones (Gordillo-Cruz et al, 2013), 2,3,4,9-tetrahydro-1 H -β-carbolines (Cárdenas-Galindo et al, 2014), 4-(pyridine-3-yl)pyrimidines (Cortes-García et al, 2016), and spiro[pyrrolidine-3,3′-oxindoles] (Alvárez-Rodríguez et al, 2018). Herein we describe the first cascade IMCR process/post-transformation strategy toward the synthesis of 4-substituted 1 H -1,2,3-triazoles linked to a fused, bis-heterocyclic peptidomimetic.…”